Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v5-EN
Language English English
Date Updated 2017-09-27 2017-06-13
Drug Identification Number 00769541 00769541
Brand name SOLYSTAT SOLYSTAT
Common or Proper name SOLYSTAT 250mg/mL U.D.SUSP SOLYSTAT 250mg/mL U.D.SUSP
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC PENDOPHARM DIVISION OF PHARMASCIENCE INC
Ingredients SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE
Strength(s) 250MG 250MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration ORAL ORAL
Packaging size 60mL 60mL
ATC code V03AE V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-06-06
Actual start date 2017-06-06 2017-06-06
Estimated end date 2017-10-02 2017-09-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments